Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, July 28, 2022
[ Thu, Jul 28th 2022
] - WOPRAI
[ Thu, Jul 28th 2022
] - WOPRAI
[ Thu, Jul 28th 2022
] - WOPRAI
[ Thu, Jul 28th 2022
] - WOPRAI
[ Thu, Jul 28th 2022
] - WOPRAI
[ Thu, Jul 28th 2022
] - WOPRAI
[ Thu, Jul 28th 2022
] - WOPRAI
[ Thu, Jul 28th 2022
] - WOPRAI
[ Thu, Jul 28th 2022
] - WOPRAI
[ Thu, Jul 28th 2022
] - WOPRAI
[ Thu, Jul 28th 2022
] - WOPRAI
[ Thu, Jul 28th 2022
] - WOPRAI
[ Thu, Jul 28th 2022
] - WOPRAI
[ Thu, Jul 28th 2022
] - WOPRAI
[ Thu, Jul 28th 2022
] - WOPRAI
[ Thu, Jul 28th 2022
] - WOPRAI
[ Thu, Jul 28th 2022
] - WOPRAI
[ Thu, Jul 28th 2022
] - WOPRAI
[ Thu, Jul 28th 2022
] - WOPRAI
[ Thu, Jul 28th 2022
] - WOPRAI
[ Thu, Jul 28th 2022
] - WOPRAI
[ Thu, Jul 28th 2022
] - WOPRAI
[ Thu, Jul 28th 2022
] - WOPRAI
[ Thu, Jul 28th 2022
] - WOPRAI
[ Thu, Jul 28th 2022
] - WOPRAI
[ Thu, Jul 28th 2022
] - WOPRAI
[ Thu, Jul 28th 2022
] - WOPRAI
Kalpit Patel Initiated (SNDX) at Strong Buy and Held Target at $31 on, Jul 28th, 2022
Kalpit Patel of B. Riley Securities, Initiated "Syndax Pharmaceuticals, Inc." (SNDX) at Strong Buy and Held Target at $31 on, Jul 28th, 2022.
Kalpit has made no other calls on SNDX in the last 4 months.
There are 2 other peers that have a rating on SNDX. Out of the 2 peers that are also analyzing SNDX, 0 agree with Kalpit's Rating of Hold.
These are the ratings of the 2 analyists that currently disagree with Kalpit
- Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $40 on, Tuesday, May 24th, 2022
- Edward White of "HC Wainwright & Co." Initiated at Strong Buy and Held Target at $31 on, Monday, April 11th, 2022
